Is treatment really reducing infections?
At least one in six patients maintains a viral load over one hundred thousand
Long-term HIV infection and poor inflammation control, not treatment, predicts risk of atherosclerosis
Optimising infant HIV treatment in resource-limited settings: when can nevirapine be used?
Six months of nevirapine prophylaxis for breastfeeding infants reduces transmission by 76% if mother not on ART
Partners study expands our knowledge of HIV transmission risk
Modellers examine the cost-effectiveness of PrEP in Africa
